ID   LIU-LSC-1 ITGA5 KO2
AC   CVCL_E5E1
RX   PubMed=36438491;
CC   Population: Chinese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6141; ITGA5.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5DZ ! LIU-LSC-1
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   PubMed=36438491; DOI=10.7150/thno.76232; PMCID=PMC9691358;
RA   Li D.-P., Sun A.-J., Zhang L., Ding Z., Yi F.-Z., Yang X., Wang Z.-X.,
RA   Chen X., Liu W.-W., Liu S.-X., Shen H.-L., Miao M.-L., Zhang L., Liu P.,
RA   Liu Y.-C., Su S.-H., Huang H.-L., Huang C., Hu Z.-D., Zhang H.-B.,
RA   Zha X.-J., Liu Y.-H.;
RT   "Elevated ITGA5 facilitates hyperactivated mTORC1-mediated progression
RT   of laryngeal squamous cell carcinoma via upregulation of EFNB2.";
RL   Theranostics 12:7431-7449(2022).
//